Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "disorder"

620 News Found

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend
Hospitals | April 14, 2026

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend

Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”


Why secure, empathetic home care defines the next era of healthcare delivery: Suhasini Deshmukh, Co-founder, MedRabbits
Opinion | April 14, 2026

Why secure, empathetic home care defines the next era of healthcare delivery: Suhasini Deshmukh, Co-founder, MedRabbits

Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs


Apollo Hospitals Navi Mumbai launches dedicated paediatric rehabilitation centre
Hospitals | April 14, 2026

Apollo Hospitals Navi Mumbai launches dedicated paediatric rehabilitation centre

The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy


Ankura Hospitals strengthens pediatric center of excellence as complex child cases rise
Hospitals | April 13, 2026

Ankura Hospitals strengthens pediatric center of excellence as complex child cases rise

Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care


Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s
Hospitals | April 11, 2026

Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s

Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply


Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
Digitisation | April 10, 2026

Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses

The device aims to bring precision neuroscience into clinical trials, accelerating drug development


Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
News | April 10, 2026

Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners

The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure


Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion
News | April 08, 2026

Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion

The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio


Alpha Cognition secures key US patent for traumatic brain injury treatment
Biopharma | April 08, 2026

Alpha Cognition secures key US patent for traumatic brain injury treatment

The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” strengthens Alpha Cognition’s existing portfolio supporting both ALPHA-1062 and ZUNVEYL


WHO updates global guidelines to combat opioid crisis
Healthcare | April 08, 2026

WHO updates global guidelines to combat opioid crisis

Opioid dependence remains a major driver of death and disease worldwide